GenVec appoints chief medical officer
Executive Summary
Thomas Davis named to the post of chief medical officer at GenVec. Davis was previously the head of the hematologic malignancies portfolio for the Cancer Therapeutics Evaluation Program at the National Cancer Institute. He will oversee clinical development of the company's gene-based product candidates. FDA placed GenVec's oncologic TNFerade on clinical hold last October after Phase II trial data revealed a potential increased risk of blood clots...